{
  "docId": "019dd923-622b-71dc-a6d9-fc4318e06f9b",
  "docSlug": "6ded4b1cfe2c",
  "documentTitle": "Bristol-Myers Squibb Company (BMY)",
  "authorId": "03_Starboard_Value",
  "authorName": "Starboard Value",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2019-03-18 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 111,
  "pageCount": 197,
  "prevPage": 110,
  "nextPage": 112,
  "slideType": "competitive_analysis",
  "function": "compare_peers",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a 'Competitive Landscape' map to visualize the density of ongoing research, contrasting the limited number of approved products with the high volume of pipeline candidates.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "bullet_list",
    "screenshot",
    "callout_box"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622b-71dc-a6d9-fc4318e06f9b/111",
  "deckHref": "/decks/019dd923-622b-71dc-a6d9-fc4318e06f9b",
  "deckJsonHref": "/decks/019dd923-622b-71dc-a6d9-fc4318e06f9b.json",
  "deckAnchorHref": "/decks/019dd923-622b-71dc-a6d9-fc4318e06f9b#slide-111",
  "components": [
    {
      "bbox": {
        "h": 0.22,
        "w": 0.35,
        "x": 0.61,
        "y": 0.65
      },
      "kind": "callout",
      "text": "While there are only two approved CAR-T therapies currently on the market, there are hundreds of pre-clinical and clinical studies underway",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "344b88b1-af1a-4cd9-a447-49d571e518ae",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.41,
        "w": 0.41,
        "x": 0.16,
        "y": 0.46
      },
      "kind": "image",
      "text": "Competitive Landscape map",
      "attrs": null,
      "subkind": "infographic",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "15b067b9-c876-4d55-8290-afb02d67c74e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.92,
        "x": 0.04,
        "y": 0.23
      },
      "kind": "list",
      "text": "Celgene has highlighted two CAR-T therapies in its pipeline – JCAR017 and bb2121. CAR-T therapy is a type of treatment that alters a patient's T-cells so that they will attack cancer cells. JCAR017 uses the CD-19 protein to target diffuse large B-cell lymphoma (DLBCL), while bb2121 targets the BCMA protein on the surface of multiple myeloma cells",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dcd4f063-62b8-4670-8342-6b1e48c15965",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.92,
        "x": 0.04,
        "y": 0.15
      },
      "kind": "paragraph",
      "text": "While there are only two chimeric antigen receptor T-cell (\"CAR-T\") therapies currently approved, the market is likely to become increasingly crowded as there are numerous studies currently underway.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dc2564ad-d107-4e61-8782-5b3bed8e556a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.96,
        "x": 0.02,
        "y": 0.89
      },
      "kind": "title",
      "text": "The CAR-T therapy market could become extremely crowded due to the number of drug candidates in development",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fab682cb-2cee-42c0-ae6c-c78d7ff41e3b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.75,
        "x": 0.04,
        "y": 0.03
      },
      "kind": "title",
      "text": "The CAR-T Therapy Market Is Likely to Become Increasingly Crowded",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0d42d363-4863-4243-87df-868750b07c27",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}